Title:
PHARMACEUTICAL COMPOSITION USED FOR REDUCING LOCALISED FAT AND USE OF PHARMACEUTICAL COMPOSITION
Document Type and Number:
WIPO Patent Application WO/2017/037593
Kind Code:
A3
Abstract:
Provided is a pharmaceutical composition used for reducing localised fat, said pharmaceutical composition including a pharmaceutically acceptable aqueous solution, a plurality of drug-containing micelles formed by a surfactant, and resveratrol coated within the drug-containing micelles. The pharmaceutical composition used for reducing localised fat reduces fat at the site of administration, and has advantages such as high stability, high fat tissue bioavailability, low side effects, and sustained release.
Inventors:
LING YU-FANG (CN)
Application Number:
PCT/IB2016/055101
Publication Date:
August 23, 2018
Filing Date:
August 26, 2016
Export Citation:
Assignee:
CALIWAY BIOPHARMACEUTICALS CO LTD (CN)
CALIWAY USA CO LTD (US)
CALIWAY USA CO LTD (US)
International Classes:
A61K31/00; A61K47/00
Domestic Patent References:
WO2014138426A2 | 2014-09-12 | |||
WO2017037593A2 | 2017-03-09 |
Foreign References:
US20110151103A1 | 2011-06-23 | |||
US200110021703A1 | ||||
US6383482B1 | 2002-05-07 | |||
US9458086B1 | 2016-10-04 |
Other References:
See also references of EP 3381473A4
Attorney, Agent or Firm:
LUNG TIN INTELLECTUAL PROPERTY AGENT LTD. (CN)
Download PDF: